Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice

Frontiers in Pharmacology(2020)10.3389/fphar.2020.513031Source: DataRank Database

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice is a research paper published in Frontiers in Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)OA: goldTopics (11)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Yanhong Guo ORCID,Hongliang He ORCID,Wenmin Yuan ORCID,Whitney N. Souery ORCID,Maria V. Fawaz ORCID

Live enrichment

PubMed:33390931

National Institutes of Health

Grant: HL068878

National Institutes of Health

Grant: HL134569

National Institutes of Health

Grant: GM113832

National Institutes of Health

Grant: T32-GM008353

National Institutes of Health

Grant: T32-GM07767

National Institutes of Health

Grant: T32-HL125242

American Foundation for Pharmaceutical Education

Grant: 15SDG24470155

American Foundation for Pharmaceutical Education

Grant: 16POST27760002

American Foundation for Pharmaceutical Education

Grant: 13SDG17230049

National Institutes of Health

Grant: 5R01HL068878-10

PPARgamma and Vascular Lesion Formation

National Institutes of Health

Grant: 5T32HL125242-09

Training Program in Translational Cardiovascular Research and Entrepreneurship

National Institutes of Health

Grant: 5K12GM088021-13

Academic Science Education and Research Training

National Institutes of Health

Grant: 5T32HL007736-15

MINORITY INSTITUTIONAL RESEARCH TRAINING PROGRAM (T32)

National Institutes of Health

Grant: 1R01HL134569-01A1

KLF14 and Atherosclerosis

National Institutes of Health

Grant: 5R01GM113832-04

Synthetic HDL_a potential sepsis therapy

National Institutes of Health

Grant: 5T32GM008353-03

BIOTECHNOLOGY TRAINING PROGRAM

National Institutes of Health

Grant: 5T32GM007767-33

Interdepartmental Training in Pharmacological Sciences

NIGMS NIH HHS

Grant: K12 GM088021

NCI NIH HHS

Grant: P30 CA118100

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2020.513031/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2020.513031/full

repositoryhttps://doaj.org/article/b2fccfd18fbd410fad12579e356f2031

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7772318

https://doi.org/10.3389/fphar.2020.513031

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

PharmacologyTherapeutics. PharmacologyRM1-950high-density lipoproteinatherosclerosischolesterol effluxcoronary artery diseaseliver X receptor

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (10)

A glimpse of the connection between PPARγ and macrophage

Frontiers in Pharmacology(2023)

co-citedsame journal

10.3389/fphar.2023.1254317

Mitochondrial TCA cycle metabolites control physiology and disease

N/A

1.2DataRank · unranked

Nature Communications(2020)

co-cited

10.1038/s41467-019-13668-3

Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human

N/A

8.9DataRank · unranked

Circulation(2020)

co-cited

10.1161/circulationaha.120.048378

Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages

Cancer Research(2020)

co-cited

10.1158/0008-5472.can-19-2994

Triacylglycerol synthesis enhances macrophage inflammatory function

Nature Communications(2020)

co-cited

10.1038/s41467-020-17881-3

Toll-Like Receptors Induce Signal-Specific Reprogramming of the Macrophage Lipidome

Cell Metabolism(2020)

co-cited

10.1016/j.cmet.2020.05.003

Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine

N/A

0.738DataRank · unranked

Proceedings of the National Academy of Sciences(2020)

co-cited

10.1073/pnas.2010682117

Paradoxical Pro-inflammatory Responses by Human Macrophages to an Amoebae Host-Adapted Legionella Effector

Cell Host & Microbe(2020)

co-cited

10.1016/j.chom.2020.03.003

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis

Nature Reviews Cardiology(2021)

co-cited

10.1038/s41569-021-00629-x

Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity

Nature Immunology(2021)

co-cited

10.1038/s41590-021-01047-4